Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?

Core Viewpoint - Allurion Technologies, Inc. (ALUR) is being evaluated for its performance relative to its peers in the Medical sector, with a focus on its year-to-date stock performance and earnings outlook [1]. Group 1: Company Performance - Allurion Technologies, Inc. is part of the Medical group, which consists of 925 companies and holds the 8 position in the Zacks Sector Rank [2]. - The Zacks Rank for ALUR is currently 2 (Buy), indicating a positive outlook based on earnings estimates and revisions [3]. - Over the past 90 days, the Zacks Consensus Estimate for ALUR's full-year earnings has increased by 73.9%, reflecting improved analyst sentiment [4]. - Year-to-date, ALUR has returned 1.6%, matching the average gain of 1.6% for the Medical group [4]. - In comparison, McKesson (MCK), another Medical stock, has outperformed with an 18.8% increase year-to-date [4]. Group 2: Industry Context - Allurion Technologies, Inc. is categorized under the Medical - Products industry, which includes 82 companies and is currently ranked 139 in the Zacks Industry Rank [5]. - Stocks in the Medical - Products industry have experienced a decline of about 1.5% year-to-date, indicating that ALUR is performing better than its industry peers [5]. - McKesson belongs to the Medical - Dental Supplies industry, which has 15 stocks and is ranked 68, with an industry gain of +7.5% year-to-date [6].